Registered Office:
Village Nandpur,,
Baddi - 174101,
Himachal Pradesh, India.
Phone : 91-1795-236196
Fax : NA
Public issue of 22,96,000 equity shares of face value of (Rs) 10/- each ("equity shares") of Beta Drugs Limited (the "company" Or the "issuer") for cash at a price of (Rs) 85/- per equity share, including a share premium of (Rs) 75/- per equity share (the "issue price"), aggregating (Rs) 19.52 crores ("the issue"), of which 1,29,600 equity shares of face value of (Rs) 10/- each for Cash at a price of (Rs) 85/- per equity share, aggregating (Rs) 1.10 crores will be reserved for subscription by the market Maker to the issue (the "market maker reservation portion"). The issue less market maker reservation portion i.e. Issue of 21,66,400 equity shares of face value of (Rs) 10 each for cash at a price of (Rs) 85/- per equity share, aggregating
(Rs) 18.42 crores is hereinafter referred to as the "net issue". The issue and the net issue will constitute 26.54% and 25.05% Respectively of the fully diluted post issue paid up equity share capital of the company.
The face value of the equity shares is (Rs) 10 each and the issue price of (Rs) 85 is 8.5 times of the face value of the Equity shares.
Opens On
Closes On
Application
Allotment
29-Sep-17
04-Oct-17
85.00-0.00
0.00-0.00
Minimum Application for shares in Nos :
1600
Further Multiples of :
1600
(Rs.Cr)
Lead Managers to the Issue
Project Cost
19.52
Pantomath Capital Advisors Pvt Ltd
Project Financed through Current Offer
19.52
Post Issue Equity Share Capital
8.65
Purchase of new plant and machinery and upgradition of the existing plant and machinery
Civil construction work at existing manufacturing plant
To obtain registration of european union GMP & Pharmaceutical Inspection Co-operation scheme
Working capital
General Corporate Purpose